AVNS icon

Avanos Medical

12.43 USD
+0.16
1.30%
At close Apr 23, 4:00 PM EDT
After hours
12.43
+0.00
0.00%
1 day
1.30%
5 days
2.73%
1 month
-13.68%
3 months
-21.33%
6 months
-44.43%
Year to date
-21.48%
1 year
-33.74%
5 years
-58.18%
10 years
-74.73%
 

About: Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.

Employees: 2,227

0
Funds holding %
of 7,419 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

23% more repeat investments, than reductions

Existing positions increased: 76 | Existing positions reduced: 62

0.89% more ownership

Funds ownership: 92.96% [Q3] → 93.85% (+0.89%) [Q4]

2% less first-time investments, than exits

New positions opened: 44 | Existing positions closed: 45

2% less funds holding

Funds holding: 258 [Q3] → 253 (-5) [Q4]

12% less call options, than puts

Call options by funds: $88K | Put options by funds: $100K

33% less capital invested

Capital invested by funds: $1.03B [Q3] → $687M (-$339M) [Q4]

100% less funds holding in top 10

Funds holding in top 10: 1 [Q3] → 0 (-1) [Q4]

Research analyst outlook

We haven’t received any recent analyst ratings for AVNS.

Financial journalist opinion

Based on 3 articles about AVNS published over the past 30 days

Positive
Zacks Investment Research
2 weeks ago
AVNS Stock Gains Following Direct Sales Deal for MIC-KEY in the UK
Avanos takes direct control of MIC-KEY sales in the UK, enhancing market presence, customer engagement and service efficiency, starting July 2025.
AVNS Stock Gains Following Direct Sales Deal for MIC-KEY in the UK
Neutral
PRNewsWire
3 weeks ago
Avanos Expands Direct Operations for MIC-KEY* Enteral Feeding Products in the UK starting July 2025
ZAVENTEM, Belgium , April 2, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) a global medical technology company, today announced that it will take direct responsibility for the sales and distribution of its MIC-KEY enteral feeding products in the United Kingdom, effective 25 July 2025. This strategic move reflects Avanos' commitment to prioritizing customer needs, enhancing product availability into the future, and providing a seamless experience for healthcare providers and patients.
Avanos Expands Direct Operations for MIC-KEY* Enteral Feeding Products in the UK starting July 2025
Negative
Zacks Investment Research
1 month ago
New Strong Sell Stocks for March 24th
AVNS, AIRS and AMPH have been added to the Zacks Rank #5 (Strong Sell) List on March 24, 2025.
New Strong Sell Stocks for March 24th
Negative
Zacks Investment Research
1 month ago
New Strong Sell Stocks for March 18th
AVNS, CARS and CABO have been added to the Zacks Rank #5 (Strong Sell) List on March 18, 2025.
New Strong Sell Stocks for March 18th
Neutral
PRNewsWire
1 month ago
Avanos Medical Announces Appointment of David Pacitti as Chief Executive Officer
ALPHARETTA, Ga. , March 17, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS), a leading medical technology company, today announced the appointment of David Pacitti as its new chief executive officer, effective April 14, 2025.
Avanos Medical Announces Appointment of David Pacitti as Chief Executive Officer
Negative
Zacks Investment Research
1 month ago
New Strong Sell Stocks for March 3rd
AVNS, CSX and STZ have been added to the Zacks Rank #5 (Strong Sell) List on March 3, 2025.
New Strong Sell Stocks for March 3rd
Positive
Zacks Investment Research
1 month ago
AVNS Stock Gains Post Q4 Earnings & Revenue Beat, Margins Contract
Strength in Avanos' Digestive Health segment drives its fourth-quarter 2024 performance despite global macroeconomic challenges.
AVNS Stock Gains Post Q4 Earnings & Revenue Beat, Margins Contract
Neutral
Seeking Alpha
1 month ago
Avanos Medical Inc. (AVNS) Q4 2024 Earnings Call Transcript
Avanos Medical Inc. (NYSE:AVNS ) Q4 2024 Earnings Conference Call February 26, 2025 9:00 AM ET Company Participants Scott Galovan - Vice President of Strategy & Corporate Development Michael Greiner - Interim Chief Executive Officer Conference Call Participants Danny Stauder - Citizens GMP Operator Good morning ladies and gentlemen. Welcome to the Avanos Fourth Quarter 2024 Earnings Call.
Avanos Medical Inc. (AVNS) Q4 2024 Earnings Call Transcript
Positive
Zacks Investment Research
1 month ago
Avanos Medical (AVNS) Q4 Earnings and Revenues Surpass Estimates
Avanos Medical (AVNS) came out with quarterly earnings of $0.43 per share, beating the Zacks Consensus Estimate of $0.40 per share. This compares to earnings of $0.36 per share a year ago.
Avanos Medical (AVNS) Q4 Earnings and Revenues Surpass Estimates
Neutral
PRNewsWire
1 month ago
Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2024 Results
ALPHARETTA, Ga. , Feb. 26, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported fourth quarter and full-year 2024 results.
Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2024 Results
Charts implemented using Lightweight Charts™